Licinio Craveiro
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Analytical and cross-sectional clinical validity of a smartphone-based U-Turn Test in multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: January 13, 2026
Efficacy and Safety of Patients With Relapsing Multiple Sclerosis Switching to Ocrelizumab Due to Suboptimal Treatment Response: Results of the 4-Year CASTING-LIBERTO Trial.
Journal: European journal of neurology
Published: November 11, 2025
Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study.
Journal: Lancet (London, England)
Published: October 30, 2025
SynSpine: an automated workflow for the generation of longitudinal spinal cord synthetic MRI data.
Journal: Frontiers in neuroinformatics
Published: June 18, 2025
Characterizing gait in people with multiple sclerosis using digital data from smartphone sensors: A proposed framework.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 18, 2025
Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: December 17, 2024
Machine learning-based prediction of disease progression in primary progressive multiple sclerosis.
Journal: Brain communications
Published: May 30, 2024
Longitudinal Multiparametric Quantitative MRI Evaluation of Acute and Chronic Multiple Sclerosis Paramagnetic Rim Lesions.
Journal: Journal of magnetic resonance imaging : JMRI
Published: April 14, 2024
Long-term analysis of infections and associated risk factors in patients with multiple sclerosis treated with ocrelizumab: pooled analysis of 13 interventional clinical trials.
Journal: Therapeutic advances in neurological disorders
Published: March 05, 2024
Five-year efficacy outcomes of ocrelizumab in relapsing multiple sclerosis: A propensity-matched comparison of the OPERA studies with other disease-modifying therapies in real-world lines of treatments.
Journal: Journal of central nervous system disease
Published: December 05, 2023
Claims-based algorithm to estimate the Expanded Disability Status Scale for multiple sclerosis in a German health insurance fund: a validation study using patient medical records.
Journal: Frontiers in neurology
Published: July 05, 2023
Last Updated: 09/26/2026